CT Scan and PET Scan Market Size, Share, Growth, and Industry Analysis, By Type (CT Scanners, PET Scanners, Hybrid PET/CT Scanners and Mobile CT & PET Scanners), By Application (Healthcare, Medical Imaging, Hospitals, Diagnostic Centers, Oncology and Emergency Services), and Regional Insights and Forecast to 2033

•   
•   
  

  Request a Free sample to learn more about this report

    

CT SCAN AND PET SCAN MARKET OVERVIEW

The global CT scan and PET scan market size was USD 13.62 billion in 2025 and is projected to touch USD 22.78 billion by 2033, exhibiting a CAGR of 5.88% during the forecast period.

A CT scan and PET scan are an advanced imaging technique that merges the structural clarity of a CT scan with the functional insight of a PET scan. The CT component can produce sensitive X-rays to create an image of cross sections of the internal body parts, such as the bones and the organs and the tissues of the body, which helps to pinpoint the location of an abnormality. When a PET scan is taken, a radioactive tracer, typically FDG is a glucose agent, is injected into the body and accumulates in the sites of high metabolism, as it normally happens in a cancerous cell. The combination allows early diagnosis of the disease by showing the cellular changes as opposed to structural changes, and it becomes particularly useful in the diagnosis, staging and monitoring of cancer and other disorders.

A CT scan and PET scan combine the anatomical images of CT with the metabolic information of PET into one session, thus providing a total body image. The combination helps the physicians to accurately detect those metabolically active areas within detailed structural images, enhancing the best diagnosis. It has been invaluable, especially in oncology, in the identification of cancer, stage of diagnosis, and treatment response. It is also used in cardiology and neurology, where it measures brain functionalities and blood circulation. CT/PET avoids duplication of scans, minimises the indeterminacy of the diagnosis and facilitates more challenging or optimal treatment planning of the different complex conditions.

COVID-19 IMPACT

Pandemic drastically reduced imaging procedures, delaying diagnoses and negatively affected the market

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

Pandemic-related disruptions were a catastrophic blow to medical imaging services, causing devastating effects on the rate of CT and PET scans. Fear of infection with effective lockdown, and by seeing overwhelming the healthcare systems, patients cancelled or delayed routine visits and elective procedures. Critical diagnostic screenings were postponed, and medical practitioners focused on emergency cases over preventive diagnostics. This reduction not only made it difficult to detect diseases early, including cancer and cardiac cases, but also reduced monitoring of ongoing treatment. The backlogs caused by this time overstretched resources and led to delays in diagnoses, which can further complicate patient outcomes. The pandemic revealed access-based healthcare vulnerabilities and interfered with the necessary medical care relying on imaging.

LATEST TRENDS

Technological innovation is transforming the market development

Technological advancement is transforming the market of medical imaging and engendering expansion in the CT scan and PET scan market. The modern process of image processing is more precise and quicker with digital CT- PET systems that make the advanced diagnostics more available for outpatient use. Artificial intelligence also augments this development through automated reading, noise processing and quick reconstruction of images, which greatly boost its performance in the diagnosis process and streamlines operations. Recent advancements in acquisition methods, such as Continuous Table Motion in CT-PET scan, Photon-Counting in CT scan, are making the image quality clearer and reducing scan time and radiation exposure. Moreover, dual-energy and functional CT scan technology offers improved tissue characterisation and metabolic information, broadening the clinical application of imaging in daily outpatient procedures.

•   
•   
  

  Request a Free sample to learn more about this report

    

CT SCAN AND PET SCAN MARKET SEGMENTATION

By Type

Based on type, the global market can be categorized into CT Scanners, PET Scanners, Hybrid PET/CT Scanners and Mobile CT & PET Scanners

• CT Scanners: The CT scanners are fitted with X-ray technology that is used to provide detailed cross-sectional cuts of the body. They assist in the precise diagnosis of trauma, cancers, vascular, as well as internal injuries. The systems are advanced and have rapid scan periods and enhanced reconstruction to provide excellent comfort and accuracy. Recent inventions also deal with lessening radiation, but still, the same quality of image must be produced. CT scanners are necessary in hospitals, ERs and medical diagnosis centers.

• PET Scanners: PET scanners have functional scanning where metabolic activity is sensed by monitoring a radioactive tracer. They are important oncology tools used in the identification, staging and follow-up of tumours. PET also plays an important role in the diagnosis of neurological diseases and heart diseases. Sensitivity and resolution have increased, and lesions of smaller size are now detectable. AI and digital sensor integration are improving diagnosis accuracy and efficiency.

• Hybrid PET/CT Scanners: Hybrid PET/CT scanners mix the ability of PET to perform metabolic imaging with the structural information provided by CT on the same machine. Such integration enhances the disease localisation, streamlines workflow, and reduces patient movement and radiation exposure. They are commonly applied in the field of oncology and provide additional clarity to the oncological staging, planning of treatment and monitoring. Latest advances such as artificial intelligence, digital detectors and acquisition modes, enhance speed and picture quality. They are also becoming more and more applicable in neurology and cardiology to make comprehensive diagnostics.

• Mobile CT & PET Scanners: Mobile CT & PET scanners offer flexible imaging solutions outside traditional hospital settings. By being mounted on vehicles or movable platforms, they bring diagnostics to distant or underserved locations. Such scanners are important in case of emergencies, relief of a disaster and temporary health facilities. They are highly portable, and this contributes to better access to care in areas where the infrastructure is scant. Mobile units support community-based healthcare by expanding diagnostic reach efficiently.

By Application

Based on application, the global market can be categorized into Healthcare, Medical Imaging, Hospitals, Diagnostic Centers, Oncology and Emergency Services

• Healthcare: Healthcare relies on CT scans and PET scan for accurate diagnosis and determination of how to handle a disease. These devices are helpful in early detection of cancer, heart and neurological conditions. They are used to make treatment decisions and also assist in tracking patients. Imaging can be used in both simple cases and complex situations in patient care. The use of advanced imaging integration has improved results and also simplified the provision of healthcare.

• Medical Imaging: Medical imaging utilises CT scan and PET scans which are used in providing detailed anatomy and functional information. CT provides structural details, whereas PET illuminates metabolism to detect early stages of disease. Together, they improve specific diagnosis and plan treatment. The non-invasive tools play an essential role in the assessment of organs and tissues and pathology. Ongoing advancements continue to increase their use in different aspects of medicine.

• Hospitals: Hospitals are primary users of CT and PET scans in the context of emergency, inpatient and outpatient services. These are the technologies that promote rapid diagnoses, surgery planning and constant tracking of the patient. Modern imaging machines and highly skilled employees enable hospitals to deal with complicated situations. Hybrid CT/PET systems further boost diagnostic precision within hospital environments. Hospitals also lead in implementing and assessing new imaging advancements.

• Diagnostic Centers: Diagnostic centers offer CT and PET scans to assist doctors with precise scans. They offer quality services available in accessible locations other than hospitals with convenient scheduling and rapid outcomes. Outpatient diagnostic centers have expanded access to essential scans for many patients. These centers are crucial in an early diagnosis and routine check-up. They are investing in the latest imaging technologies to be able to compete.

• Oncology: Oncology heavily relies on CT and PET scans regarding cancer detection and staging. CT/PET enables accurate tumour localisation and metabolic evaluation and can be used to influence treatment decisions. These scans check the success of the therapy and act as an early warning of recurrence. Imaging is used by oncologists to provide customised care to patients and enhance outcomes. Integration of structural and functional information has revolutionised how cancer is diagnosed and treated.

• Emergency Services: Emergency services use CT and PET scans to assess acute and trauma damage in emergency rooms. In severe cases, CT plays a very important role in finding internal injuries, bleeding, and fractures. PET can be used in order to evaluate shocking neurological problems and vague symptoms. Speed and accuracy in imaging enable prompt treatment and better survival rates. Mobile and on-site imaging units are enhancing emergency response capabilities.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

Rising prevalence of chronic diseases to boost the market

The rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and nervous disorders are very much contributing significantly to the expanding market of CT scan and PET scan market growth. Such complicated conditions require advanced imaging tools to facilitate early diagnosis, staging as well as monitoring the treatment process. With an increased emphasis on preventive care and precision medicine in the global healthcare system, there should be an increased interest in high-resolution anatomical detection (CT) and functional metabolic evaluation (PET). This has seen more people adopting the hybrid CT/PET systems, which will provide all the diagnostic capability in a single session. Consequently, the market is growing at a stable rate and the hospitals and diagnostic facilities are investing a huge cost in state-of-the-art imaging infrastructure to cope with the increasing demands of the patients.

Growing demand for early and accurate diagnosis to expand the market

The growing demand to diagnose early and accurate diagnosis is another driving force shaping the CT and PET scan industry. As healthcare goes toward preventive medicine and precision, clinicians are leaning toward non-invasive tools to help find diseases at their earliest and most treatable stages. This has seen the growth in adoption of highly acceptable imaging systems capable of supplying high-resolution anatomical and functional data without the need for surgery. The use of Hybrid CT/PET specifically allows full analysis with the integration of structural and metabolic data, and this can provide the ability of a physician to focus on the area of interest concerning abnormalities. Technological advancements are also led by the need to have quicker and more efficient diagnosis, increasing the clinical utility and the market area penetration of these imaging modalities.

Restraining Factor

High capital and operational costs hamper the market

High capital and operational costs present a major barrier to the growth of the CT and PET scan market. The start-up costs of these scanners are high in terms of the actual expenses incurred in purchasing them, their installation and configuration which in most cases can be expensive. Moreover, routine repair, specialised personnel requirements and expenses associated with radiation safety and regulatory compliance further burden budgets. Smaller hospitals, diagnostic centers and other healthcare facilities, especially in developing regions, find these financial burdens more costly. Consequently, most institutions find it very difficult to acquire or upgrade to advanced imaging facilities that will provide the most needed diagnostic services. This significantly restricts market expansion and creates disparities in healthcare delivery and imaging availability.

Healthcare infrastructure development and awareness to create opportunities for the market

Opportunity

Healthcare infrastructure and the increased levels of awareness regarding the need for CT and PET scans to detect diseases at very early stages, especially in developing economies, are creating market opportunities. Governments and the commercial sectors have been increasing their healthcare expenditure, which has contributed to the growth of diagnostic healthcare facilities, enabling more of them to be provided with modern imaging systems.

The early and accurate diagnosis is also one of those points to which patients and providers were made aware in the conditions of public health campaigns and medical education initiatives. Consequently, the pressure of non-invasive imaging technologies is rising, particularly in circular care and outpatient facilities. Among them is market penetration, which is growing, increasing the use of the CT and PET technologies, and access to diagnostic services in various regions across the world.

Limited reimbursement policies to challenge the market

Challenge

The challenge of limited reimbursement policies is challenging in countries where funding of healthcare is restricted. Poor or variable reimbursements of advanced imaging discourage the provision of such services by healthcare providers, in particular in the outpatient and privately managed settings. Inadequate coverage of scan costs may often compel patients who can afford to pay the high attendance fees to withhold or cancel necessary diagnostic reports, thus lowering the level of access.

This cost overhead also discourages better developments in these facilities due to reduced willingness on the part of hospitals/diagnosis centers to invest in up-to-date imaging devices, further limiting technological progressions. This deprivation of supportive reimbursement models has detrimental outcomes on market growth, inequalities in access and delayed diagnosis and treatment capabilities in different regions and healthcare systems.

•   
•   
  Request a Free sample to learn more about this report

    

CT SCAN AND PET SCAN MARKET REGIONAL INSIGHTS

• North America

North America dominates the global CT scan and PET scan market share due to the high rate of adoption of strong healthcare infrastructure and huge spending on healthcare. The number of CT scan units in the U.S. in the CT and PET scan market alone is more than 4,500 units and 850 PET/CT systems are installed in the region. Chronic conditions such as cancer, cardiovascular diseases are prevalent and favourable Medicare and private insurer reimbursement policies drive the market. High research and development, fast-evolving technologies involving AI adoption and whole-body PET platforms, and the growing adoption of hybrid and mobile systems also contribute to growth. The United States CT scan and PET scan market is the most important market maker in North America.

• Europe

Europe holds a strong position in the global CT and PET scan market, with more than 3,800 CT and 700 PET/CT units. Other such countries as Germany, France, and the U.K. enjoy having efficient healthcare structures, large use of cutting-edge imaging and centralised funding. The major drive are an increasing number of senior citizens, growing rates of chronic illness and favourable regulatory and research environments. There is an increased acceptance of hybrid imaging and mobile diagnostic services in the area, especially in the field of oncology.

• Asia

The Asia Pacific CT and PET scan market is growing with more than 4,200 CT systems and 650 PET/CT scans. Countries such as China, Japan and India are improving access to high-quality imaging, due to rapid growth of the healthcare infrastructure, increasing medical spending and increased awareness of the importance of early diagnosis. Incentives by the government, local production and the growing demand in rural hospitals are also pushing the change, particularly with the purchase of hybrid CT/PET scan systems in the middle-tier hospitals and outpatient care facilities.

KEY INDUSTRY PLAYERS

Key industry players are expanding their product portfolios for market expansion

Key industry players are expanding their product range to support the diverse requirements of the CT and PET scan market in diverse healthcare settings. The availability of scanners with a variety of features and supporting various budgets with entry-level scanners priced on the lower end of the market, and more expensive, feature-rich technology on the other end of the scale is enabling companies to serve the needs of hospitals, diagnostic centers and outpatient clinics with various budgets and diagnostic needs. The strategic diversification helps in enhancing wider market penetration, especially in the developing regions. There is also an introduction of portable and mobile imaging solutions to reach more remote and underserved locations, on-site diagnostics in community health initiatives, disaster response and rural clinics. These innovations are indispensable in enhancing access as well as closing gaps in advanced diagnostic imaging services globally.

List Of Top Ct Scan And Pet Scan Companies

• Siemens Healthineers (Germany)
• GE Healthcare (U.S.)
• Philips Healthcare (Netherlands)
• Canon Medical Systems Corporation (Japan)
• Hitachi Medical Systems (Japan)
• Shimadzu Corporation (Japan)
• Neusoft Medical Systems (China)
• United Imaging Healthcare (China)
• Positron Corporation (U.S.)
• Mediso Ltd. (Hungary)

KEY INDUSTRY DEVELOPMENT

January 2025: New AI techniques, such as the work of the AutoPET competition, improve significantly the detection of tumours in CT and PET images through automatic segmentation of lesions. These algorithms save time by analysing medical images efficiently and more accurately through deep learning. Compared to individual models, ensemble models are better, as they can precisely locate the tumour and estimate size, and could become fully automated in clinical diagnostics in the future.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

CT Scan and PET Scan market is experiencing notable growth as key industry players expand their product portfolios to address diverse healthcare demands. Manufacturers are offering a wide range of systems from budget-friendly entry-level models to advanced, premium scanners catering to hospitals, diagnostic centers, and outpatient facilities with varying financial capacities. Additionally, the rise of portable and mobile imaging units is improving access in underserved and rural areas. These innovations support on-site diagnostics in disaster zones, remote clinics, and community health programs. This strategic diversification enhances global market reach, supports early disease detection, and bridges disparities in access to advanced diagnostic imaging technologies.